Back

Long term safety analysis of transvenous vs subcutaneous implantable cardioverter defibrillators: a propensity score matched analysis

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Antibradycardia Pacing Device Treatment EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Daniel Jorge Nascimento Matos

Hospital de Santa Cruz, Carnaxide (Portugal)

21 More presentations in this session

Presentation thumbnail
Heart failure risk in patients with chronic right ventricular pacing: an observational study
Professor B. Kichou (Tizi-ouzou, DZ)
Presentation thumbnail
Electrophysiological assessment of His-bundle pacing
Doctor D. Yoshimoto (Toyohashi, JP)
Abstract
Presentation thumbnail
Biatrial pacing using a canted left ventricular lead in the distal coronary sinus: one-year results from a series of six cases
Mr M. Schrage (Berlin, DE)
Abstract Slides
Presentation thumbnail
Improving the safety and efficiency of CIED implantation procedures with pre-procedural contrast-enhanced venography
Assistant Professor J. Taleski (Skopje, MK)
Abstract Slides
Presentation thumbnail
Importance of RV lead placement in patients undergoing pacemaker implantation with expected high RV pacing and the development of heart failure and early detection in cardiac MRI
Doctor V. Johnson (Frankfurt, DE)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Antibradycardia Pacing

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources